Cargando…

Immunotherapy of experimental and human stroke with agents approved for multiple sclerosis: a systematic review

BACKGROUND: ‘Thromboinflammation’ describes a novel concept in stroke pathophysiology that has opened up the possibility of immunotherapeutic approaches which could become promising strategies for targeted stroke therapies in the future. METHODS: We reviewed current evidence for agents approved for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dreikorn, Mirjam, Milacic, Zeljko, Pavlovic, Vladimir, Meuth, Sven G., Kleinschnitz, Christoph, Kraft, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949925/ https://www.ncbi.nlm.nih.gov/pubmed/29774055 http://dx.doi.org/10.1177/1756286418770626

Ejemplares similares

Advances in Multiple Sclerosis 2017
por: Göbel, Kerstin, et al.
Publicado: (2018)

Glatiramer acetate does not protect from acute ischemic stroke in mice
por: Kraft, Peter, et al.
Publicado: (2014)

Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-Analysis
por: Förster, Moritz, et al.
Publicado: (2021)

CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke
por: Schuhmann, Michael K, et al.
Publicado: (2015)

Experimental immunotherapies for multiple sclerosis
por: Martin, Roland, et al.
Publicado: (1996)

Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment
por: Rolfes, Leoni, et al.
Publicado: (2021)

Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine
por: Rolfes, Leoni, et al.
Publicado: (2023)

Comparing Plasma Exchange to Escalated Methyl Prednisolone in Refractory Multiple Sclerosis Relapses
por: Pfeuffer, Steffen, et al.
Publicado: (2019)

Ischemia-induced cell depolarization: does the hyperpolarization-activated cation channel HCN2 affect the outcome after stroke in mice?
por: Ehling, Petra, et al.
Publicado: (2013)

The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders
por: Pankratz, Susann, et al.
Publicado: (2016)

Next-generation antithrombotics in ischemic stroke: preclinical perspective on ‘bleeding-free antithrombosis'
por: Kraft, Peter, et al.
Publicado: (2012)

Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab
por: Pfeuffer, Steffen, et al.
Publicado: (2021)

Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
por: Rolfes, Leoni, et al.
Publicado: (2021)

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy
por: Graf, Jonas, et al.
Publicado: (2017)

Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod—potentials and risks of subsequent highly active agents
por: Korsen, Melanie, et al.
Publicado: (2022)

Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment
por: Schönfelder, Kristina, et al.
Publicado: (2021)

Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis
por: Marziniak, Martin, et al.
Publicado: (2014)

Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood
por: Hohmann, Christopher, et al.
Publicado: (2014)

Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis
por: Wiendl, Heinz, et al.
Publicado: (2015)

Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke
por: Schuhmann, Michael K., et al.
Publicado: (2016)

B cells do not have a major pathophysiologic role in acute ischemic stroke in mice
por: Schuhmann, Michael K., et al.
Publicado: (2017)

The genetic aspects of multiple sclerosis
por: Sawcer, Stephen
Publicado: (2009)

Circular RNAs in Ischemic Stroke: Biological Role and Experimental Models
por: Siracusa, Chiara, et al.
Publicado: (2023)

Report on the 1st scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Mittenwalde/Motzen, Germany, Oct. 30th - Nov. 1st, 2009
por: Magnus, Tim, et al.
Publicado: (2010)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021)

Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
por: Andrade, Bruno Silva, et al.
Publicado: (2020)

Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment
por: Haas, Jürgen, et al.
Publicado: (2019)

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
por: Ruck, Tobias, et al.
Publicado: (2015)

Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination
por: Longoria, Victor, et al.
Publicado: (2022)

Report on the 3'rd scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Motzen, Germany, Nov. 4'th - Nov. 6'th, 2011
por: Kleinschnitz, Christoph, et al.
Publicado: (2012)

Report on the 2nd scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Motzen, Germany, Oct. 29'th - Oct. 31'st, 2010
por: Magnus, Tim, et al.
Publicado: (2011)

Report on the 5‘th scientific meeting of the “Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie” (NEUROWIND e.V.) held in Motzen, Germany, Oct. 25th – Oct. 27th, 2013
por: Linker, Ralf A, et al.
Publicado: (2013)

Report on the 4'th scientific meeting of the “Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie” (NEUROWIND e.V.) held in Motzen, Germany, Nov. 2’nd – Nov. 4’th, 2012
por: Linker, Ralf A, et al.
Publicado: (2012)

Fingolimod (FTY720-P) Does Not Stabilize the Blood–Brain Barrier under Inflammatory Conditions in an in Vitro Model
por: Schuhmann, Michael K., et al.
Publicado: (2015)

Report on the 7th scientific meeting of the Association for the Advancement of Young Academics in Neurology (NEUROWIND e.V.) held in Motzen, Germany, October 30–November 1, 2015
por: Korn, Thomas, et al.
Publicado: (2016)

Report on the 6th scientific meeting of the “Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie” (NEUROWIND e.V.) held in Motzen, Germany, Oct. 31th – Nov. 2nd, 2014
por: Kleinschnitz, Christoph, et al.
Publicado: (2015)

Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022)

The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2023)

The Effects of the Microbial Biostimulants Approved by EU Regulation 2019/1009 on Yield and Quality of Vegetable Crops
por: Fusco, Giovanna Marta, et al.
Publicado: (2022)

COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic stroke
por: Kraft, Peter, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_78b8n67hm4j4uip13dfbfb7f5u